PharmaLegacy Laboratories (Shanghai) Co., Ltdis a Osteoarthritis Model,Humanized micein one large multi-functional integrated modern enterprise,and devote the high-quality Non-Human Primates models and first-class service for the masses of customers.

   PharmaLegacy Laboratories (Shanghai) Co., Ltd is specialized in Business services,Medical service,Medical insurance since established in 10 years ago.So far,our company has established its branch companies in major cities throughout the country.Formed in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China as the center, the radiation sales system and service network.Details:With fully validated rheumatoid arthritis model and the state-of-art equipments, PharmaLegacy provides exceptional services for preclinical pharmacology studies of the drug candidates for rheumatoid arthritis model treatment, including:· Evaluation of therapeutic profile and potentials of the candidate compounds· Proof of concept for early drug development· Demonstration of differential regulation of disease progression and clinical symptoms· Examination of anti-autoimmune disorder as well as anti-inflammatory effect such as T cell and B cell response, and cytokine/chemokine response· Investigation of the mechanisms of immunological tolerance induction

   Adhering to the Sincere service, the pursuit of perfection spirit of enterprise, PharmaLegacy bases on long-term development, technology as the core, market-oriented, and constantly open up new areas, undertaking to provide fast, high-quality service for the vast numbers of users. For further information about PharmaLegacyAutoimmuneDiseasesModelx2a38631n, please visit our official website: www.pharmalegacy.com.

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings